HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Wu Selected Research

Ephrin-B2 (Ephrin B2)

2/2022Downregulation of EphB2 by RNA interference attenuates glial/fibrotic scar formation and promotes axon growth.
1/2021EphB2 knockdown decreases the formation of astroglial-fibrotic scars to promote nerve regeneration after spinal cord injury in rats.
10/2017RNAi-mediated ephrin-B2 silencing attenuates astroglial-fibrotic scar formation and improves spinal cord axon growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Wu Research Topics

Disease

271Neoplasms (Cancer)
12/2022 - 05/2002
90Hepatocellular Carcinoma (Hepatoma)
05/2022 - 05/2004
54Stomach Neoplasms (Stomach Cancer)
08/2022 - 07/2002
52Infections
04/2022 - 07/2002
52Neoplasm Metastasis (Metastasis)
01/2022 - 05/2002
42Inflammation (Inflammations)
10/2022 - 11/2005
39Fibrosis (Cirrhosis)
05/2022 - 01/2006
28Cardiomegaly (Heart Hypertrophy)
01/2022 - 06/2010
28Carcinogenesis
12/2021 - 10/2003
24COVID-19
06/2022 - 01/2020
21Cataract (Cataracts)
04/2022 - 12/2008
19Wounds and Injuries (Trauma)
12/2021 - 09/2008
17Heart Failure
01/2022 - 01/2012
17Liver Neoplasms (Liver Cancer)
05/2021 - 12/2009
17Ischemia
01/2020 - 01/2006
17Carcinoma (Carcinomatosis)
01/2019 - 04/2000
16AIDS-Related Complex (ARC)
01/2022 - 09/2008
15Liver Diseases (Liver Disease)
01/2022 - 02/2002
15Prostatic Neoplasms (Prostate Cancer)
06/2021 - 08/2002
14Breast Neoplasms (Breast Cancer)
01/2022 - 10/2003
14Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 04/2006
14Hypertension (High Blood Pressure)
01/2021 - 12/2010
13Myocardial Infarction
01/2022 - 04/2009
13Hypoxia (Hypoxemia)
01/2022 - 02/2011
13Hypertrophy
01/2022 - 05/2011
13Urinary Bladder Neoplasms (Bladder Cancer)
02/2020 - 02/2012
13Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 08/2008
12Malaria
01/2022 - 01/2014
11Atherosclerosis
10/2022 - 05/2011
11Hepatitis B
05/2021 - 04/2002
11Body Weight (Weight, Body)
01/2021 - 09/2005
11Infarction (Infarctions)
01/2020 - 06/2012
10Necrosis
06/2021 - 12/2008
10Lung Neoplasms (Lung Cancer)
06/2020 - 05/2002
10Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 04/2005
9Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 10/2006
9Non-alcoholic Fatty Liver Disease
10/2021 - 07/2014
9Pain (Aches)
09/2021 - 02/2009
9Lymphatic Metastasis
08/2021 - 07/2011
9Stroke (Strokes)
05/2021 - 11/2013
9Insulin Resistance
01/2021 - 05/2005
9Cholangiocarcinoma
01/2021 - 06/2013
9Pathologic Constriction (Stenosis)
03/2020 - 06/2005
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2019 - 05/2002
9Colonic Neoplasms (Colon Cancer)
02/2015 - 11/2009
8Sepsis (Septicemia)
09/2022 - 09/2018
8Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2022 - 01/2015
8Thrombosis (Thrombus)
10/2021 - 02/2004
8Diabetes Mellitus
01/2021 - 12/2009
8Virus Diseases (Viral Diseases)
01/2021 - 03/2004
8Death (Near-Death Experience)
07/2020 - 06/2015
7Burns
11/2021 - 12/2009

Drug/Important Bio-Agent (IBA)

113Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2003
63Biomarkers (Surrogate Marker)IBA
10/2022 - 04/2002
41MicroRNAs (MicroRNA)IBA
07/2021 - 03/2010
35Biological ProductsIBA
01/2022 - 04/2003
35Pharmaceutical PreparationsIBA
01/2022 - 09/2010
35Messenger RNA (mRNA)IBA
01/2022 - 10/2003
27DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2002
24CytokinesIBA
06/2022 - 05/2005
19Long Noncoding RNAIBA
12/2021 - 03/2014
18AntigensIBA
01/2022 - 10/2004
18RNA (Ribonucleic Acid)IBA
01/2022 - 02/2006
15LigandsIBA
02/2021 - 05/2003
14AntibodiesIBA
06/2022 - 02/2005
14Indicators and Reagents (Reagents)IBA
01/2022 - 01/2015
14CollagenIBA
01/2021 - 12/2009
14EnzymesIBA
01/2021 - 05/2002
13Small Interfering RNA (siRNA)IBA
01/2020 - 10/2004
12CateninsIBA
01/2022 - 06/2016
12Monoclonal AntibodiesIBA
01/2021 - 04/2003
11Therapeutic UsesIBA
06/2022 - 11/2011
11VaccinesIBA
03/2022 - 06/2013
11Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2010
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2000
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2009
10Phosphotransferases (Kinase)IBA
01/2022 - 01/2015
10Transcription Factors (Transcription Factor)IBA
01/2020 - 03/2008
9Angiotensin IIIBA
01/2022 - 06/2010
9LipidsIBA
10/2021 - 11/2005
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 05/2005
9omega-Chloroacetophenone (Mace)IBA
01/2021 - 09/2018
9alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2020 - 04/2005
8Sorafenib (BAY 43-9006)FDA Link
01/2021 - 01/2015
8Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 09/2010
8Histones (Histone)IBA
04/2018 - 03/2004
76-methyladenineIBA
05/2022 - 01/2019
7AutoantibodiesIBA
03/2022 - 09/2010
7Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 04/2002
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2010
7Immunoglobulin G (IgG)IBA
01/2022 - 02/2014
7Matrix Metalloproteinases (MMPs)IBA
11/2021 - 11/2009

Therapy/Procedure

93Therapeutics
05/2022 - 10/2003
62Liver Transplantation
05/2022 - 02/2002
24Drug Therapy (Chemotherapy)
01/2022 - 08/2007
15Transplantation
01/2022 - 06/2005
14Immunotherapy
01/2022 - 10/2004
11Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2022 - 06/2010
11Radiotherapy
12/2021 - 05/2004
8Lasers (Laser)
01/2022 - 01/2007